Villanova, PA, United States of America

David A Simmons

USPTO Granted Patents = 4 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2021

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by David A Simmons

Introduction

David A Simmons is an accomplished inventor based in Villanova, PA (US). He has made significant contributions to the field of diabetes care through his innovative inventions. With a total of 4 patents, Simmons has focused on developing systems and methods that enhance the management of analyte concentration levels.

Latest Patents

One of Simmons' latest patents is titled "Apparatus, systems, and methods for determining and displaying pre-event and post-event analyte concentration levels." This invention provides apparatus and systems that collect and process pre-event and post-event analyte concentration readings associated with specific events. The goal is to determine a numerical delta that can be displayed visually, aiding in the assessment of how an event, along with medication or insulin dosages, affects analyte concentration levels. The invention also allows for the display of medication and insulin dosages alongside the numerical delta, facilitating immediate relationships between these factors.

Career Highlights

David A Simmons is currently associated with Ascensia Diabetes Care Holdings AG, where he continues to innovate in the field of diabetes management. His work has been instrumental in developing technologies that improve patient outcomes and enhance the understanding of glucose levels in relation to various events.

Collaborations

Simmons has collaborated with notable colleagues, including Jeffery S Reynolds and Paul M Ripley. Their combined expertise has contributed to the advancement of diabetes care technologies.

Conclusion

David A Simmons is a prominent inventor whose work in diabetes care has led to significant advancements in the field. His innovative patents and collaborations reflect his commitment to improving health outcomes for individuals managing diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…